from Stocks-Markets-Economic Times https://ift.tt/3b8d95E
Home »
Stocks-Markets-Economic Times
» Covid drug: Natco eyes patent waiver
Covid drug: Natco eyes patent waiver
from Stocks-Markets-Economic Times https://ift.tt/3b8d95E
Related Posts:
SAT stays Sebi’s Rs 6-cr penalty on NSEThe Securities and Exchange Board of India (Sebi) had accused NSE of violating these rules by purchasing stakes in half a dozen companies including Computer Age Management Systems (CAMS), Power Exchange India (PXIL) and NSDL … Read More
Stocks in the news: TCS, Kotak Mahindra Bank, DHFL, Airtel and Indian BankKotak Bank said the RBI has approved the re-appointment of Uday Kotak as MD of the bank for a further period of three years. from Stocks-Markets-Economic Times https://ift.tt/2K3OLrq … Read More
Sebi proposes listing rule tweaks for startupsThe regulator has proposed that the compulsory shareholding period before listing for investors owning 25% or higher stake be halved to one year. from Stocks-Markets-Economic Times https://ift.tt/2KqMzu0 … Read More
SGX Nifty down 30 points; here's what changed for market while you were sleepingNifty futures on the Singapore Exchange traded 31 points, or 0.23 per cent, lower at 13,560.50, in signs that Dalal Street was headed for a negative start on Tuesday. from Stocks-Markets-Economic Times https://ift.tt/34d3KGa… Read More
Asian stocks dip as investors curb vaccine enthusiasmAustralian S&P/ASX 200 lost 0.12 per cent in early trading while Japan's Nikkei 225 futures fell 0.13 per cent. E-mini futures for the S&P 500 rose 0.21 per cent. from Stocks-Markets-Economic Times https://ift.tt/3qX… Read More
0 Comments:
Post a Comment